Physician

Jamie L Mcginness, M.D.

According to 2025 Medicare claims, Jamie Mcginness, M.D. (NPI: 1447291356) practices dermatology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Clair, IL. This provider's primary affiliated billing organization is METRO EAST DERMATOLOGY & SKIN CANCER CENTER LLC (NPI: 1518494996; TIN: 821544325) and primary practice location at 62269-1887. Mcginness is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Mcginness' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 617 traditional Medicare patients, billed 1,568 HCPCS/CPT codes, and received $388,670 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 307 prescription claims across 263 beneficiaries totaling $17,009 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 4 records totaling $117. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $267,591 to $388,670. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $13,077 and ending at $17,009. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	326	1,209	$267,591
2016	352	1,183	$266,232
2017	382	1,207	$213,826
2018	747	2,775	$501,600
2019	638	2,100	$522,112
2020	648	2,115	$478,843
2021	684	2,386	$496,348
2022	655	2,259	$428,036
2023	534	1,481	$353,902
2024	617	1,568	$388,670

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	230	425	$13,077
2016	231	389	$7,914
2017	175	263	$13,543
2018	382	660	$30,299
2019	378	592	$17,020
2020	306	430	$12,742
2021	256	341	$9,418
2022	294	383	$12,493
2023	224	295	$36,648
2024	263	307	$17,009

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	396	482	$462
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	72	97	$314
12032	Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm	65	67	$201
12052	Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm	132	136	$122
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	92	97	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	130	4,062	$8,938
Cephalexin	Cephalexin	110	777	$355
Doxycycline Hyclate	Doxycycline Hyclate	33	238	$210
Mupirocin	Mupirocin	11	203	$107

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$117	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jamie L. Mcginness, M.D.?

Tedicare shows public-source Medicare data for Jamie L. Mcginness, M.D. (NPI 1447291356), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jamie L. Mcginness, M.D. have ACO affiliation data?

Jamie L. Mcginness, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Jamie L. Mcginness, M.D.?

Jamie L. Mcginness, M.D. is linked to METRO EAST DERMATOLOGY & SKIN CANCER CENTER LLC (billing NPI 1518494996) in the available physician profile data.

Does Jamie L. Mcginness, M.D. have Open Payments data?

Jamie L. Mcginness, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.